JP5000794B2 - 標的核酸を増幅して検出するための方法 - Google Patents

標的核酸を増幅して検出するための方法 Download PDF

Info

Publication number: JP5000794B2
Authority: JP; Japan
Prior art keywords: nucleic acid; target nucleic; amplified; amplification; labeled
Prior art date: 1996-03-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

JP05633797A

Other languages

English (en)

Japanese (ja)

Other versions

JPH1033198A (ja

Inventor

ウェスリーバッカスジョン

リンクラマーマルシア

ファルボジョセフ

Original Assignee

オルソ−クリニカルダイアグノスティクス，インコーポレイティド

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-11

Filing date

1997-03-11

Publication date

2012-08-15

1997-03-11 Application filed by オルソ−クリニカルダイアグノスティクス，インコーポレイティド filed Critical オルソ−クリニカルダイアグノスティクス，インコーポレイティド

1998-02-10 Publication of JPH1033198A publication Critical patent/JPH1033198A/ja

2012-08-15 Application granted granted Critical

2012-08-15 Publication of JP5000794B2 publication Critical patent/JP5000794B2/ja

2017-03-11 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

150000007523 nucleic acids Chemical class 0.000 title claims abstract description 101
108020004707 nucleic acids Proteins 0.000 title claims abstract description 94
102000039446 nucleic acids Human genes 0.000 title claims abstract description 94
238000000034 method Methods 0.000 title claims abstract description 54
238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 66
230000003321 amplification Effects 0.000 claims abstract description 38
238000011534 incubation Methods 0.000 claims abstract description 37
102000016928 DNA-directed DNA polymerase Human genes 0.000 claims abstract description 32
108010014303 DNA-directed DNA polymerase Proteins 0.000 claims abstract description 31
230000000295 complement effect Effects 0.000 claims abstract description 21
239000000523 sample Substances 0.000 claims description 45
102000004190 Enzymes Human genes 0.000 claims description 29
108090000790 Enzymes Proteins 0.000 claims description 29
239000003153 chemical reaction reagent Substances 0.000 claims description 13
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 12
239000001226 triphosphate Substances 0.000 claims description 11
108091034117 Oligonucleotide Proteins 0.000 claims description 9
235000011178 triphosphate Nutrition 0.000 claims description 9
239000007787 solid Substances 0.000 claims description 8
-1 nucleoside triphosphates Chemical class 0.000 claims description 7
229960002685 biotin Drugs 0.000 claims description 6
235000020958 biotin Nutrition 0.000 claims description 6
239000011616 biotin Substances 0.000 claims description 6
238000006243 chemical reaction Methods 0.000 claims description 6
239000002777 nucleoside Substances 0.000 claims description 6
230000009870 specific binding Effects 0.000 claims description 6
108010006785 Taq Polymerase Proteins 0.000 claims description 4
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical group C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 4
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 4
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims description 4
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 4
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 claims description 4
239000003446 ligand Substances 0.000 claims description 4
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims description 4
102000003992 Peroxidases Human genes 0.000 claims description 3
241000589499 Thermus thermophilus Species 0.000 claims description 3
239000005549 deoxyribonucleoside Substances 0.000 claims description 3
108040007629 peroxidase activity proteins Proteins 0.000 claims description 3
108090001008 Avidin Proteins 0.000 claims description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 2
239000007800 oxidant agent Substances 0.000 claims description 2
239000000758 substrate Substances 0.000 claims description 2
241000205180 Thermococcus litoralis Species 0.000 claims 1
HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims 1
238000001514 detection method Methods 0.000 abstract description 53
239000012985 polymerization agent Substances 0.000 abstract description 5
238000003752 polymerase chain reaction Methods 0.000 description 42
239000000047 product Substances 0.000 description 33
229940088598 enzyme Drugs 0.000 description 25
108020004414 DNA Proteins 0.000 description 21
230000035945 sensitivity Effects 0.000 description 12
241000700605 Viruses Species 0.000 description 10
238000004925 denaturation Methods 0.000 description 10
230000036425 denaturation Effects 0.000 description 10
239000011541 reaction mixture Substances 0.000 description 10
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
108060002716 Exonuclease Proteins 0.000 description 8
102000013165 exonuclease Human genes 0.000 description 8
239000000463 material Substances 0.000 description 8
239000002773 nucleotide Substances 0.000 description 8
125000003729 nucleotide group Chemical group 0.000 description 8
239000000243 solution Substances 0.000 description 8
239000012807 PCR reagent Substances 0.000 description 7
239000000872 buffer Substances 0.000 description 7
239000000975 dye Substances 0.000 description 7
238000007834 ligase chain reaction Methods 0.000 description 7
230000037452 priming Effects 0.000 description 7
108010061982 DNA Ligases Proteins 0.000 description 6
102000012410 DNA Ligases Human genes 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 6
230000000155 isotopic effect Effects 0.000 description 6
241000894006 Bacteria Species 0.000 description 5
108091028043 Nucleic acid sequence Proteins 0.000 description 5
238000012408 PCR amplification Methods 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
238000009396 hybridization Methods 0.000 description 5
239000000203 mixture Substances 0.000 description 5
239000002245 particle Substances 0.000 description 5
241000894007 species Species 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
238000012360 testing method Methods 0.000 description 5
241000701022 Cytomegalovirus Species 0.000 description 4
108700034637 EC 3.2.-.- Proteins 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
241000204031 Mycoplasma Species 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
230000001413 cellular effect Effects 0.000 description 4
238000010438 heat treatment Methods 0.000 description 4
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
108020005187 Oligonucleotide Probes Proteins 0.000 description 3
108010090804 Streptavidin Proteins 0.000 description 3
102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 3
108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 3
230000027455 binding Effects 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
238000007796 conventional method Methods 0.000 description 3
238000011161 development Methods 0.000 description 3
230000000694 effects Effects 0.000 description 3
230000002255 enzymatic effect Effects 0.000 description 3
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 3
229960005542 ethidium bromide Drugs 0.000 description 3
239000002751 oligonucleotide probe Substances 0.000 description 3
235000018102 proteins Nutrition 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
239000007858 starting material Substances 0.000 description 3
239000000725 suspension Substances 0.000 description 3
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
230000004544 DNA amplification Effects 0.000 description 2
ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
241000606768 Haemophilus influenzae Species 0.000 description 2
108010001336 Horseradish Peroxidase Proteins 0.000 description 2
208000026350 Inborn Genetic disease Diseases 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
241000233872 Pneumocystis carinii Species 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
241000589596 Thermus Species 0.000 description 2
241000589500 Thermus aquaticus Species 0.000 description 2
238000000137 annealing Methods 0.000 description 2
230000008901 benefit Effects 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000004027 cell Anatomy 0.000 description 2
238000011109 contamination Methods 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
108010052305 exodeoxyribonuclease III Proteins 0.000 description 2
238000000605 extraction Methods 0.000 description 2
210000002950 fibroblast Anatomy 0.000 description 2
210000003953 foreskin Anatomy 0.000 description 2
208000016361 genetic disease Diseases 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
208000006454 hepatitis Diseases 0.000 description 2
231100000283 hepatitis Toxicity 0.000 description 2
230000006872 improvement Effects 0.000 description 2
230000000415 inactivating effect Effects 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000011160 research Methods 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
BBMHARZCALWXSL-UHFFFAOYSA-M sodium dihydrogenphosphate monohydrate Chemical compound O.[Na+].OP(O)([O-])=O BBMHARZCALWXSL-UHFFFAOYSA-M 0.000 description 2
239000013589 supplement Substances 0.000 description 2
238000005406 washing Methods 0.000 description 2
SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 1
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
PDDRBNDSMILNJH-UHFFFAOYSA-N 4-[4,5-bis[4-(dimethylamino)phenyl]-1H-imidazol-2-yl]-2-methoxyphenol Chemical compound C1=C(O)C(OC)=CC(C=2NC(=C(N=2)C=2C=CC(=CC=2)N(C)C)C=2C=CC(=CC=2)N(C)C)=C1 PDDRBNDSMILNJH-UHFFFAOYSA-N 0.000 description 1
YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
LELMRLNNAOPAPI-UFLZEWODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid;aminophosphonous acid Chemical compound NP(O)O.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 LELMRLNNAOPAPI-UFLZEWODSA-N 0.000 description 1
102100028247 Abl interactor 1 Human genes 0.000 description 1
108050004693 Abl interactor 1 Proteins 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
108020000946 Bacterial DNA Proteins 0.000 description 1
241000589968 Borrelia Species 0.000 description 1
241000606161 Chlamydia Species 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
241000193163 Clostridioides difficile Species 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
238000007400 DNA extraction Methods 0.000 description 1
108010046855 DNA-deoxyinosine glycosidase Proteins 0.000 description 1
AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
108010007577 Exodeoxyribonuclease I Proteins 0.000 description 1
102100029075 Exonuclease 1 Human genes 0.000 description 1
102000008857 Ferritin Human genes 0.000 description 1
108050000784 Ferritin Proteins 0.000 description 1
238000008416 Ferritin Methods 0.000 description 1
108020000949 Fungal DNA Proteins 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
101001066878 Homo sapiens Polyribonucleotide nucleotidyltransferase 1, mitochondrial Proteins 0.000 description 1
206010020460 Human T-cell lymphotropic virus type I infection Diseases 0.000 description 1
241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
241000701806 Human papillomavirus Species 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
241000589242 Legionella pneumophila Species 0.000 description 1
241000186781 Listeria Species 0.000 description 1
208000016604 Lyme disease Diseases 0.000 description 1
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
241001502334 Mycobacterium avium complex bacterium Species 0.000 description 1
241000187479 Mycobacterium tuberculosis Species 0.000 description 1
241000202934 Mycoplasma pneumoniae Species 0.000 description 1
QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
102000002681 Polyribonucleotide nucleotidyltransferase Human genes 0.000 description 1
241000205156 Pyrococcus furiosus Species 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
241000607768 Shigella Species 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
241000205188 Thermococcus Species 0.000 description 1
241001135650 Thermotoga sp. Species 0.000 description 1
241000589498 Thermus filiformis Species 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
108010092464 Urate Oxidase Proteins 0.000 description 1
108020000999 Viral RNA Proteins 0.000 description 1
241000607734 Yersinia <bacteria> Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
239000012491 analyte Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
230000008859 change Effects 0.000 description 1
238000004891 communication Methods 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000005289 controlled pore glass Substances 0.000 description 1
238000001816 cooling Methods 0.000 description 1
UFJPAQSLHAGEBL-RRKCRQDMSA-N dITP Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(N=CNC2=O)=C2N=C1 UFJPAQSLHAGEBL-RRKCRQDMSA-N 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
230000029087 digestion Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
229940125532 enzyme inhibitor Drugs 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
108010092809 exonuclease Bal 31 Proteins 0.000 description 1
108010032819 exoribonuclease II Proteins 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
238000011842 forensic investigation Methods 0.000 description 1
239000000499 gel Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
108010055863 gene b exonuclease Proteins 0.000 description 1
230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
239000003292 glue Substances 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
229940115932 legionella pneumophila Drugs 0.000 description 1
125000005647 linker group Chemical group 0.000 description 1
238000004020 luminiscence type Methods 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
159000000003 magnesium salts Chemical class 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
239000011572 manganese Substances 0.000 description 1
229910052748 manganese Inorganic materials 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
150000004712 monophosphates Chemical class 0.000 description 1
JULKJDRBSRRBHT-UHFFFAOYSA-N n-(3-chloro-4-hydroxyphenyl)acetamide Chemical compound CC(=O)NC1=CC=C(O)C(Cl)=C1 JULKJDRBSRRBHT-UHFFFAOYSA-N 0.000 description 1
238000001821 nucleic acid purification Methods 0.000 description 1
125000003835 nucleoside group Chemical group 0.000 description 1
244000052769 pathogen Species 0.000 description 1
229960003330 pentetic acid Drugs 0.000 description 1
239000008055 phosphate buffer solution Substances 0.000 description 1
150000008300 phosphoramidites Chemical class 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000008569 process Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
244000000040 protozoan parasite Species 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000004153 renaturation Methods 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
238000004007 reversed phase HPLC Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
229940050865 sodium phosphate,monobasic,monohydrate Drugs 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
XZTJQQLJJCXOLP-UHFFFAOYSA-M sodium;decyl sulfate Chemical compound [Na+].CCCCCCCCCCOS([O-])(=O)=O XZTJQQLJJCXOLP-UHFFFAOYSA-M 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000013456 study Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
229940048102 triphosphoric acid Drugs 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
241000712461 unidentified influenza virus Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
230000003612 virological effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Physics & Mathematics (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Immunology (AREA)
Analytical Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Plant Pathology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Saccharide Compounds (AREA)
Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

JP05633797A 1996-03-11 1997-03-11 標的核酸を増幅して検出するための方法 Expired - Fee Related JP5000794B2 (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US61357196A	1996-03-11	1996-03-11
US08/613571		1996-03-11

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2012019550A Division JP2012105663A (ja)	1996-03-11	2012-02-01	標的核酸を増幅して検出するための方法

Publications (2)

Publication Number	Publication Date
JPH1033198A JPH1033198A (ja)	1998-02-10
JP5000794B2 true JP5000794B2 (ja)	2012-08-15

Family

ID=24457826

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP05633797A Expired - Fee Related JP5000794B2 (ja)	1996-03-11	1997-03-11	標的核酸を増幅して検出するための方法

Country Status (13)

Country	Link
US (1)	US6280930B1 (fr)
EP (1)	EP0795612B1 (fr)
JP (1)	JP5000794B2 (fr)
KR (1)	KR100442196B1 (fr)
CN (1)	CN1309838C (fr)
AT (1)	ATE248928T1 (fr)
AU (1)	AU1514397A (fr)
CA (1)	CA2199213C (fr)
DE (1)	DE69724487T2 (fr)
DK (1)	DK0795612T3 (fr)
ES (1)	ES2205121T3 (fr)
NO (1)	NO324530B1 (fr)
PT (1)	PT795612E (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPO524897A0 (en) *	1997-02-21	1997-03-20	Johnson & Johnson Research Pty. Limited	Method of amplifying specific nucleic acid target sequences
US6558901B1 (en) *	1997-05-02	2003-05-06	Biomerieux Vitek	Nucleic acid assays
IL124275A (en) *	1997-05-02	2002-03-10	Bio Merieux Vitek Inc	A method to produce sequences of nucleic acids
WO2000079009A2 (fr)	1999-06-22	2000-12-28	Invitrogen Corporation	Amorces et procedes ameliores destines a la detection et a la discrimination d'acides nucleiques
US6830902B1 (en)	1999-07-02	2004-12-14	Invitrogen Corporation	Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
US20030165859A1 (en)	2001-10-23	2003-09-04	Invitrogen Corporation	Primers and methods for the detection and discrimination of nucleic acids
US8841069B2 (en) *	2005-12-29	2014-09-23	Korea Materials & Analysis Corporation	Dendron-mediated DNA virus detection
WO2007079129A2 (fr) *	2005-12-29	2007-07-12	Industrial Cooperation Agency	Diagnostic en une etape au moyen d'une puce a adn
GB0806041D0 (en)	2008-04-03	2008-05-14	Genomica S A	Method for detection of herpesvirus in test sample
CN112322793A (zh) *	2020-11-30	2021-02-05	中国科学院化学研究所	一种基于ccp-fret的rna病毒快速检测的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4683195A (en)	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en)	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
US5635347A (en) *	1986-04-30	1997-06-03	Igen, Inc.	Rapid assays for amplification products
CA1317535C (fr)	1987-06-30	1993-05-11	Nanibhushan Dattagupta	Essai de sequences a l'aide de genes amplifies
US5229297A (en) *	1989-02-03	1993-07-20	Eastman Kodak Company	Containment cuvette for PCR and method of use
ES2100945T3 (es) *	1989-12-22	1997-07-01	Hoffmann La Roche	Transcriptasas reversas de alta temperatura.
US5210015A (en)	1990-08-06	1993-05-11	Hoffman-La Roche Inc.	Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5344045A (en) *	1990-12-17	1994-09-06	The Coca-Cola Company	Liquid container system
CA2065719A1 (fr) *	1991-04-30	1992-10-31	John B. Findlay	Amplification d'acides nucleiques et methodes de detection faisant appel au cycle rapide de la reaction en chaine a la polymerase
IT1255737B (it) *	1992-05-19	1995-11-15		Reattore multitubolare a film cadente
WO1994003635A1 (fr) *	1992-08-04	1994-02-17	Institute Of Molecular Biology & Biotechnology	Amplification et detection rapides d'acides nucleiques
US5645801A (en) *	1993-10-21	1997-07-08	Abbott Laboratories	Device and method for amplifying and detecting target nucleic acids
WO1996006190A2 (fr) *	1994-08-19	1996-02-29	Perkin-Elmer Corporation	Procede de ligature et d'amplification associees

1997
- 1997-03-05 CA CA002199213A patent/CA2199213C/fr not_active Expired - Fee Related
- 1997-03-06 AU AU15143/97A patent/AU1514397A/en not_active Abandoned
- 1997-03-10 KR KR1019970007874A patent/KR100442196B1/ko not_active Expired - Fee Related
- 1997-03-10 NO NO19971086A patent/NO324530B1/no not_active IP Right Cessation
- 1997-03-11 CN CNB971096201A patent/CN1309838C/zh not_active Expired - Fee Related
- 1997-03-11 AT AT97301591T patent/ATE248928T1/de active
- 1997-03-11 ES ES97301591T patent/ES2205121T3/es not_active Expired - Lifetime
- 1997-03-11 EP EP97301591A patent/EP0795612B1/fr not_active Expired - Lifetime
- 1997-03-11 DE DE69724487T patent/DE69724487T2/de not_active Expired - Lifetime
- 1997-03-11 DK DK97301591T patent/DK0795612T3/da active
- 1997-03-11 PT PT97301591T patent/PT795612E/pt unknown
- 1997-03-11 JP JP05633797A patent/JP5000794B2/ja not_active Expired - Fee Related
- 1997-04-25 US US08/845,739 patent/US6280930B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2199213C (fr)	2007-04-17
EP0795612A2 (fr)	1997-09-17
JPH1033198A (ja)	1998-02-10
DE69724487T2 (de)	2004-07-01
NO324530B1 (no)	2007-11-12
PT795612E (pt)	2004-02-27
KR970065730A (ko)	1997-10-13
EP0795612B1 (fr)	2003-09-03
NO971086D0 (no)	1997-03-10
CN1165862A (zh)	1997-11-26
EP0795612A3 (fr)	1999-03-24
KR100442196B1 (ko)	2004-11-20
ES2205121T3 (es)	2004-05-01
DE69724487D1 (de)	2003-10-09
CN1309838C (zh)	2007-04-11
NO971086L (no)	1997-09-12
AU1514397A (en)	1997-09-18
ATE248928T1 (de)	2003-09-15
US6280930B1 (en)	2001-08-28
CA2199213A1 (fr)	1997-09-11
DK0795612T3 (da)	2003-12-15

Legal Events

Date	Code	Title	Description
2004-02-19	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040218
2007-11-14	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071113
2008-02-13	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080212
2008-02-18	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080215
2008-05-10	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080509
2009-08-05	A02	Decision of refusal	Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090804
2009-11-28	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091127
2009-12-14	A911	Transfer to examiner for re-examination before appeal (zenchi)	Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20091211
2010-03-01	A912	Re-examination (zenchi) completed and case transferred to appeal board	Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20100226
2011-01-13	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110112
2011-01-18	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110117
2011-11-02	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111101
2011-11-08	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111107
2012-02-02	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120201
2012-03-15	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120314
2012-04-19	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01
2012-05-24	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120517
2012-05-25	R150	Certificate of patent or registration of utility model	Free format text: JAPANESE INTERMEDIATE CODE: R150
2012-05-28	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20150525 Year of fee payment: 3
2015-05-25	LAPS	Cancellation because of no payment of annual fees

Publication	Publication Date	Title
US6001558A (en)	1999-12-14	Amplification and detection of HIV-1 and/or HIV 2
JP4298814B2 (ja)	2009-07-22	播種性マイコバクテリウム・アビウム複合体感染を検出するための多重化ｐｃｒアッセイ
EP0592035B1 (fr)	1996-01-03	Composition de polymérase d'ADN thermostable contenant un inhibiteur à température, kits pour des tests diagnostiques et son utilisation
JP3514630B2 (ja)	2004-03-31	核酸配列の増幅および検出
EP0702090B1 (fr)	2004-05-06	Procédé pour la coamplification d'acide nucléique utilisant un agent d'exclusion volumique dans la composition de réaction, trousse d'analyse et dispositif de test
US5702901A (en)	1997-12-30	Diagnostic compositions, elements, methods and test kits for amplification and detection of two or more DNA's using primers having matched melting temperatures
US5403707A (en)	1995-04-04	Diagnostic compositions, elements, methods and test kits for amplification and detection of retroviral DNA using primers having matched melting temperatures
JP4047395B2 (ja)	2008-02-13	核酸の同時増幅方法
AU741141B2 (en)	2001-11-22	Specific and sensitive method for detecting nucleic acids
JP5000794B2 (ja)	2012-08-15	標的核酸を増幅して検出するための方法
US5968739A (en)	1999-10-19	Nucleic acid primers and probes for detecting Legionella pneumophila
JPH04229200A (ja)	1992-08-18	改良ｌｃｒ法
JPH1118785A (ja)	1999-01-26	ナイセリア・コノルホエア−特異的オリゴヌクレオチド
US5559013A (en)	1996-09-24	Method of amplification using intermediate renaturation step
AU768981B2 (en)	2004-01-15	Amplifying and detecting target nucleic acids using a post amplification incubation step
JP2012105663A (ja)	2012-06-07	標的核酸を増幅して検出するための方法
EP0586011A2 (fr)	1994-03-09	Procédés de production et d'amplification d'acides nucléiques
JPH074275B2 (ja)	1995-01-25	核酸を増幅して検出するための方法及び診断試験キット
KR20240023114A (ko)	2024-02-20	Lida(lesion induced dna amplification)에 의한 sars-cov-2 분석
JPH04503458A (ja)	1992-06-25	核酸の増殖方法